Formulation and characterization of a stable vinorelbine-PAMAM conjugate loaded liposomes

Samantray Satyaswarup 1, * and Sharma Shailesh 2

1 Dept. of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur. Cell phone No. 7702686117.
2 Principal & Professor School of Pharmaceutical Sciences Dr.K.N.Modi University, Newai, Tonk.
 
Research Article
World Journal of Advanced Research and Reviews, 2020, 05(01), 068-072
Article DOI: 10.30574/wjarr.2020.5.1.0111
 
Publication history: 
Received on 30 December 2019; revised on 17 January 2020; accepted on 20 January 2020
 
Abstract: 
The cancer activity of vinorelbine is primarily due to inhibition of mitosis during metaphase of cell division process and its interaction with tubulin. The aqueous solubility of the vinorelbine is > 1000 mg/mL in distilled water. Prolonged vinorelbine exposure is resulted in improved antineoplastic effects, as evident by improved response rate during patients receiving a continuous infusion of the drug. A phase-I pharmacokinetic study of the vinorelbine liposomal injection has been reported and concluded well tolerated and exhibited more favourable pharmacokinetic profiles than free vinorelbine. Dendrimers are new class of artificial macromolecules. Dendrimer possess a well-defined topological structure, are versatile candidates as scaffolds or vehicles for nanomedicine the field of cancer diagnosis and therapy. Dendrimers can be used for conjugating of anticancer compounds and by non-covalent interactions (ionic, hydrophobic, hydrogen-bond interactions) and spacer-mediated conjugates. Also, they can be used for targeting to cancer cells, tumour tissues or abnormal vessels adjacent to the disease focus based on the molecular ‘‘hooks’’ conjugated on the surface of dendrimer through active targeting, and can be accumulated in tumours via the enhanced permeability and retention (EPR) effect of the nanosized dendrimer through passive targeting effect of the nanosized dendrimer through passive targeting. Targeting to tumour tissues & prolonged release profile can further improved by encapsulating vinorelbine-PAMAM conjugated inside liposome. In this study we formulated and characterized a stable vinorelbine-PAMAM conjugate liposomal formulation.
 
Keywords: 
Vinorelbine; PAMAM dendrimer conjugate; Cancer; Characterization; Stability; Liposomal formulation.
 
Full text article in PDF: 
Share this